intellectual property


TPP 11 Sydney meeting vindicates community concerns
TPP 11 negotiators have agreed to suspend controversial clauses on medicine monopolies and some governments want to renegotiate other clauses, vindicating public interest group concerns
Vietnam proposes amendments to stalled TPP trade deal at Sydney talks: sources
Officials from 11 of the 12 countries that committed to the Trans-Pacific Partnership (TPP) trade deal are meeting in Sydney for talks to re-energize the stalled agreement and discuss amendmends to the pact following the withdrawal of the US.
Health community's concerns re TPP11 proposed next steps
Stronger intellectual property protection would benefit the US in return for no concessions, civil society groups tell TPP11 Ministers
Internet freedom and public interest groups concerns re TPP11 proposed next steps
Stronger intellectual property protection does not benefit the TPP11 but would benefit the US in return for no concessions by the USA, a civil society letter to ministers asserts
Pharmaceutical prices, intellectual property rights emerge as key issues in KORUS FTA discussions
Through the KORUS revision, the US is openly seeking to bridge its trade deficit with Korea by renegotiating specific terms for individual product categories.
Neelam Deo on EU-India’s perplexing relationship: Trade, Europe’s hypocrisy and China concern
Former diplomat says the EU’s insistence on opening up on wine imports from France and automobile imports from Germany have held up the EU-India FTA negotiations.
Big pharma, IP wars and profit over people
At RCEP negotiations held in India, intellectual property rights issues in medicine remain contentious
NAFTA could replay TPP biologics debate
A battle over the length of data protection for biologic medicine appears to be shaping up in the NAFTA negotiations in a replay of an issue that helped block the Trans-Pacific Partnership from becoming law.
Business groups to the administration: Keep ISDS in NAFTA
More than 100 U.S. business groups and associations are pushing the Trump administration to not only preserve investor-state dispute settlement and related provisions in an updated NAFTA agreement but to also strengthen them to further protect intellectual property and interests.
Interview with Loon Gangte
Loon Gangte is an Indian activist living with HIV and hepatitis C, founder of the Delhi Network of Positive People.